PR Newswire
SOUTH SAN FRANCISCO, California
and
VANCOUVER, Canada
,
June 2, 2022
/PRNewswire/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the 2022 Jefferies Healthcare Conference in
New York City
on
Thursday, June 9, 2022
at
3:00 p.m. Eastern Time
.
David. R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will participate in and host one-on-one meetings.
David S. Wood
, ESSA’s Chief Financial Officer, will also be participating in the one-on-one meetings.
Presentation Details
|
|
|
|
|
|
|
|
|
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit
www.essapharma.com
and follow us on Twitter under
@ESSAPharma
.
A webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA’s website at
www.essapharma.com
. Following the presentation, the webcast will be archived for 90 days.
View original content:
https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-2022-jefferies-healthcare-conference-301559630.html
SOURCE ESSA Pharma Inc
